Analysis of Nasdaq-100 Index Reshuffle
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Source: seekingalpha
- Strong Performers Added: Nebius Group (NBIS) leads the new entrants with a year-to-date gain of 165.5%, indicating robust growth potential that may attract further investor interest in the tech sector.
- Lagging Stocks Removed: Insmed (INSM) has seen a significant decline of 44.4% year-to-date, making it the worst performer among those removed, yet Wall Street analysts maintain a Strong Buy rating, reflecting confidence in its future recovery.
- Analyst Rating Discrepancies: Among the ten companies added and removed, only Nebius (NBIS) received a Strong Buy rating from the Quant model, while Insmed (INSM) was rated Sell, highlighting a notable divergence between quantitative assessments and Wall Street sentiment.
- Shift in Industry Focus: The latest reshuffle underscores Nasdaq's increasing emphasis on AI, semiconductors, cloud infrastructure, and space-related themes, while removing underperforming stocks, potentially guiding future investment strategies.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy TER?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on TER
Wall Street analysts forecast TER stock price to fall
18 Analyst Rating
13 Buy
4 Hold
1 Sell
Moderate Buy
Current: 347.590
Low
161.00
Averages
206.12
High
240.00
Current: 347.590
Low
161.00
Averages
206.12
High
240.00
About TER
Teradyne, Inc. is a global supplier of automated test equipment and robotics solutions. It designs, develops, manufactures and sells automated test systems and robotics products. Its segment includes Semiconductor Test, Robotics, and Product Test. The Semiconductor Test segment includes operations related to the design, manufacturing and marketing of semiconductor test products and services, inclusive of storage and system level test products. The Robotics segment includes operations related to the design, manufacturing and marketing of collaborative robotic arms and autonomous mobile robots. The Product Test segment includes operations related to the design, manufacturing and marketing of products and services for defense/aerospace test, circuit-board test, wireless test systems, and silicon photonics testing. Its offerings also include defense/aerospace test instrumentation and systems, circuit-board test and inspection (production board test) systems, and wireless test systems.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Analysis of Nasdaq-100 Index Reshuffle
- Strong Performers Added: Nebius Group (NBIS) leads the new entrants with a year-to-date gain of 165.5%, indicating robust growth potential that may attract further investor interest in the tech sector.
- Lagging Stocks Removed: Insmed (INSM) has seen a significant decline of 44.4% year-to-date, making it the worst performer among those removed, yet Wall Street analysts maintain a Strong Buy rating, reflecting confidence in its future recovery.
- Analyst Rating Discrepancies: Among the ten companies added and removed, only Nebius (NBIS) received a Strong Buy rating from the Quant model, while Insmed (INSM) was rated Sell, highlighting a notable divergence between quantitative assessments and Wall Street sentiment.
- Shift in Industry Focus: The latest reshuffle underscores Nasdaq's increasing emphasis on AI, semiconductors, cloud infrastructure, and space-related themes, while removing underperforming stocks, potentially guiding future investment strategies.
See More
ARK Investment Management's Massive Selloff Ahead of SpaceX IPO
- Massive Selloff: ARK Investment Management offloaded approximately $222.87 million in shares on Thursday, with the largest transaction being $76.6 million in Teradyne stock, indicating a strategic shift ahead of the SpaceX IPO.
- Diverse Divestments: In addition to Teradyne, ARK sold shares in Twist Bioscience, Iridium Communications, and Robinhood Markets, totaling $64.2 million, reflecting a portfolio optimization strategy across multiple companies.
- SpaceX IPO Outlook: Priced at $135 per share with a staggering $1.77 trillion valuation, SpaceX's IPO is one of the most anticipated events on Wall Street, and while ARK's selloff may be related, the exact funding intentions remain unconfirmed.
- Retail Investor Sentiment: On Stocktwits, retail sentiment around the SPCX ticker has remained in 'extremely bullish' territory over the past week, with a 663% surge in chatter over the last 24 hours, indicating strong market interest in the upcoming IPO.
See More
CRWV and NBIS to Join Nasdaq-100 Index
- Nasdaq-100 Inclusion: CRWV and NBIS stocks are set to join the Nasdaq-100 index on June 22, with market expectations that this will drive their stock prices higher as index funds and ETFs are required to purchase shares to track the index.
- Stock Performance: Following the Nasdaq announcement, CRWV and NBIS jumped 7% and 8% respectively in pre-market trading, reflecting strong investor confidence in the surge of demand for AI infrastructure, particularly given both companies' leading positions in cloud computing.
- Financial Growth: CoreWeave reported a 111% year-over-year revenue increase to $2.08 billion in the last quarter, indicating robust demand in the AI workload cloud computing market, while Nebius's stock surged 342% over the past 12 months, showcasing its successful expansion in AI infrastructure.
- Analyst Sentiment: Analysts are more bullish on CRWV, with 23 out of 36 analysts rating it as 'Buy' or higher, compared to only 9 out of 16 analysts giving 'Buy' or higher ratings for NBIS, indicating strong market confidence in CRWV's prospects.
See More
CRWV and NBIS to Join Nasdaq-100 Index
- New Nasdaq-100 Members: CRWV and NBIS stocks will join the Nasdaq-100 index on June 22, with CRWV and NBIS jumping 7% and 8% respectively in pre-market trading, enhancing their visibility and market recognition among investors.
- Beneficiaries of AI Boom: CoreWeave and Nebius, as cloud computing service providers, are capitalizing on the AI surge, with CoreWeave's quarterly revenue increasing by 111% year-over-year to $2.08 billion, indicating strong market demand and growth potential.
- Shift in Investor Sentiment: Retail sentiment for CRWV shifted from 'neutral' to 'bullish', with analysts optimistic about its prospects, as 23 out of 36 analysts rated it 'Buy', anticipating ETF inflows to further drive up the stock price.
- Competitive Market Dynamics: Nebius saw its stock price soar by 342% over the past year and secured a $27 billion contract with Meta Platforms, showcasing its strong competitiveness and market appeal in the AI infrastructure sector.
See More
Nasdaq-100 Index Quarterly Rebalance Announced
- New Additions: The June 2026 quarterly rebalance will add Astera Labs, CoreWeave, Nebius Group, Rocket Lab, and Teradyne to the Nasdaq-100 Index, indicating their growth potential and increasing investor interest in these companies.
- Removals: Charter Communications, Cognizant, Insmed, Verisk Analytics, and Zscaler will be removed from the index, reflecting their relative underperformance in the market, which may impact shareholder confidence and future financing capabilities.
- Index Influence: The Nasdaq-100 Index tracks over $800 billion in assets across investment products, and the changes in its composition will directly affect its performance, influencing investors' asset allocation strategies.
- Market Reaction Anticipation: The changes will take effect on June 22, 2026, prompting market participants to monitor the performance of the newly added companies to assess their potential impact on overall market sentiment and investment trends.
See More
Analysis of Investment Choices in Robotics and Automation
- Return Comparison: As of May 30, the ARK Autonomous Technology & Robotics ETF delivered a 79.99% return over the past year, significantly outperforming the Invesco QQQ ETF's 42.71%, indicating that investments focused on robotics and automation may yield higher short-term gains.
- Holding Structure Analysis: The ARK ETF holds 40 stocks, with the top five accounting for 37%, including Tesla at 10.34%, suggesting that the fund's concentrated investments in specific sectors may pose high risks but also potential high rewards.
- Long-Term Performance Evaluation: Despite the ARK fund's strong recent performance, the Invesco QQQ ETF has achieved an annualized return of 21.8% since its inception in 2014, demonstrating its stability and reliability for long-term investors.
- Fee and Diversification Considerations: The ARK fund charges a management fee of 0.75%, while the Invesco QQQ's fee is only 0.18%, making the latter more attractive in terms of cost efficiency, and its 102-stock diversification also reduces investment risk.
See More
Analysis of Nasdaq-100 Index Reshuffle
- Strong Performers Added: Nebius Group (NBIS) leads the new entrants with a year-to-date gain of 165.5%, indicating robust growth potential that may attract further investor interest in the tech sector.
- Lagging Stocks Removed: Insmed (INSM) has seen a significant decline of 44.4% year-to-date, making it the worst performer among those removed, yet Wall Street analysts maintain a Strong Buy rating, reflecting confidence in its future recovery.
- Analyst Rating Discrepancies: Among the ten companies added and removed, only Nebius (NBIS) received a Strong Buy rating from the Quant model, while Insmed (INSM) was rated Sell, highlighting a notable divergence between quantitative assessments and Wall Street sentiment.
- Shift in Industry Focus: The latest reshuffle underscores Nasdaq's increasing emphasis on AI, semiconductors, cloud infrastructure, and space-related themes, while removing underperforming stocks, potentially guiding future investment strategies.
See More
ARK Investment Management's Massive Selloff Ahead of SpaceX IPO
- Massive Selloff: ARK Investment Management offloaded approximately $222.87 million in shares on Thursday, with the largest transaction being $76.6 million in Teradyne stock, indicating a strategic shift ahead of the SpaceX IPO.
- Diverse Divestments: In addition to Teradyne, ARK sold shares in Twist Bioscience, Iridium Communications, and Robinhood Markets, totaling $64.2 million, reflecting a portfolio optimization strategy across multiple companies.
- SpaceX IPO Outlook: Priced at $135 per share with a staggering $1.77 trillion valuation, SpaceX's IPO is one of the most anticipated events on Wall Street, and while ARK's selloff may be related, the exact funding intentions remain unconfirmed.
- Retail Investor Sentiment: On Stocktwits, retail sentiment around the SPCX ticker has remained in 'extremely bullish' territory over the past week, with a 663% surge in chatter over the last 24 hours, indicating strong market interest in the upcoming IPO.
See More
CRWV and NBIS to Join Nasdaq-100 Index
- Nasdaq-100 Inclusion: CRWV and NBIS stocks are set to join the Nasdaq-100 index on June 22, with market expectations that this will drive their stock prices higher as index funds and ETFs are required to purchase shares to track the index.
- Stock Performance: Following the Nasdaq announcement, CRWV and NBIS jumped 7% and 8% respectively in pre-market trading, reflecting strong investor confidence in the surge of demand for AI infrastructure, particularly given both companies' leading positions in cloud computing.
- Financial Growth: CoreWeave reported a 111% year-over-year revenue increase to $2.08 billion in the last quarter, indicating robust demand in the AI workload cloud computing market, while Nebius's stock surged 342% over the past 12 months, showcasing its successful expansion in AI infrastructure.
- Analyst Sentiment: Analysts are more bullish on CRWV, with 23 out of 36 analysts rating it as 'Buy' or higher, compared to only 9 out of 16 analysts giving 'Buy' or higher ratings for NBIS, indicating strong market confidence in CRWV's prospects.
See More
CRWV and NBIS to Join Nasdaq-100 Index
- New Nasdaq-100 Members: CRWV and NBIS stocks will join the Nasdaq-100 index on June 22, with CRWV and NBIS jumping 7% and 8% respectively in pre-market trading, enhancing their visibility and market recognition among investors.
- Beneficiaries of AI Boom: CoreWeave and Nebius, as cloud computing service providers, are capitalizing on the AI surge, with CoreWeave's quarterly revenue increasing by 111% year-over-year to $2.08 billion, indicating strong market demand and growth potential.
- Shift in Investor Sentiment: Retail sentiment for CRWV shifted from 'neutral' to 'bullish', with analysts optimistic about its prospects, as 23 out of 36 analysts rated it 'Buy', anticipating ETF inflows to further drive up the stock price.
- Competitive Market Dynamics: Nebius saw its stock price soar by 342% over the past year and secured a $27 billion contract with Meta Platforms, showcasing its strong competitiveness and market appeal in the AI infrastructure sector.
See More
Nasdaq-100 Index Quarterly Rebalance Announced
- New Additions: The June 2026 quarterly rebalance will add Astera Labs, CoreWeave, Nebius Group, Rocket Lab, and Teradyne to the Nasdaq-100 Index, indicating their growth potential and increasing investor interest in these companies.
- Removals: Charter Communications, Cognizant, Insmed, Verisk Analytics, and Zscaler will be removed from the index, reflecting their relative underperformance in the market, which may impact shareholder confidence and future financing capabilities.
- Index Influence: The Nasdaq-100 Index tracks over $800 billion in assets across investment products, and the changes in its composition will directly affect its performance, influencing investors' asset allocation strategies.
- Market Reaction Anticipation: The changes will take effect on June 22, 2026, prompting market participants to monitor the performance of the newly added companies to assess their potential impact on overall market sentiment and investment trends.
See More
Analysis of Investment Choices in Robotics and Automation
- Return Comparison: As of May 30, the ARK Autonomous Technology & Robotics ETF delivered a 79.99% return over the past year, significantly outperforming the Invesco QQQ ETF's 42.71%, indicating that investments focused on robotics and automation may yield higher short-term gains.
- Holding Structure Analysis: The ARK ETF holds 40 stocks, with the top five accounting for 37%, including Tesla at 10.34%, suggesting that the fund's concentrated investments in specific sectors may pose high risks but also potential high rewards.
- Long-Term Performance Evaluation: Despite the ARK fund's strong recent performance, the Invesco QQQ ETF has achieved an annualized return of 21.8% since its inception in 2014, demonstrating its stability and reliability for long-term investors.
- Fee and Diversification Considerations: The ARK fund charges a management fee of 0.75%, while the Invesco QQQ's fee is only 0.18%, making the latter more attractive in terms of cost efficiency, and its 102-stock diversification also reduces investment risk.
See More
